QQQ
+ 0.00
393.82
+ 0%
BTC/USD
+ 136.59
57087.15
+ 0.24%
DIA
-0.08
344.98
-0.02%
SPY
+ 0.33
455.23
+ 0.07%
TLT
+ 0.00
151.59
+ 0%
GLD
-0.02
165.52
-0.01%

Expert Ratings For Biogen

October 19, 2021 12:08 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Expert Ratings For Biogen

Over the past 3 months, 13 analysts have published their opinion on Biogen (NASDAQ:BIIB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company’s business to predict how a stock will trade over the upcoming year.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 6 2 5 0 0
Last 30D 1 0 0 0 0
1M Ago 3 1 3 0 0
2M Ago 1 0 0 0 0
3M Ago 1 1 2 0 0

In the last 3 months, 13 analysts have offered 12-month price targets for Biogen. The company has an average price target of $376.38 with a high of $455.00 and a low of $290.00.

Below is a summary of how these 13 analysts rated Biogen over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the move negative analysts are on the stock

price target chart

This current average represents a 6.68% increase from the previous average price target of $403.33.

Analyst Ratings: What Are They?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company’s revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Posted-In:

Analyst Ratings

Related Articles

Where Biogen Stands With Analysts

Where Biogen Stands With Analysts

Biogen (NASDAQ:BIIB) has observed the following analyst ratings within the last quarter: read more
Expert Ratings For Biogen

Expert Ratings For Biogen

Analysts have provided the following ratings for Biogen (NASDAQ:BIIB) within the last quarter: read more
Analyst Ratings For Biogen

Analyst Ratings For Biogen

Analysts have provided the following ratings for Biogen (NASDAQ:BIIB) within the last quarter: read more
Analyst Ratings For Biogen

Analyst Ratings For Biogen

Biogen (NASDAQ:BIIB) has observed the following analyst ratings within the last quarter: read more